newsfilter
← Latest News
PR Newswire·

Eiger BioPharmaceuticals Announces New Data Supporting Broader Potential of Avexitide in Patients with Post-Bariatric Hypoglycemia and Hyperinsulinemic Hypoglycemia After Gastrointestinal Surgeries

- Data presented in oral presentation at ENDO 2022 on June 11 - Avexitide significantly reduced the number of hypoglycemia events and the amount of time spent in hypoglycemia - Study included patients who had undergone gastric bypass, vertical